SILO
Silo Pharma, Inc.
Key Financials
Gross Profit
$27807
↓ 58.0%
Net Income
$-4227698
↑ 3.8%
Operating Income
$-4280662
↑ 9.0%
Revenue
$72102
0.0%
Total Assets
$7.6M
↑ 2.6%
EPS (Diluted)
$-0.50
↑ 58.0%
Total Liabilities
$1.3M
↓ 45.3%
Cash & Equivalents
$4.7M
↑ 21.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 424B3 | 4/16/2026 | View on SEC |
| EFFECT | 4/15/2026 | View on SEC |
| 424B3 | 4/14/2026 | View on SEC |
| POS AM | 4/14/2026 | View on SEC |
| EFFECT | 4/13/2026 | View on SEC |
| POS AM | 4/10/2026 | View on SEC |
| 8-K | 4/2/2026 | View on SEC |
| 10-K | 3/27/2026 | View on SEC |
| 8-K | 2/23/2026 | View on SEC |
| SCHEDULE 13G/A | 2/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SILO |
| Company Name | Silo Pharma, Inc. |
| CIK | 1514183 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | (718) 400-9031 |